enVVeno Medical Statistics Share Statistics enVVeno Medical has 19.25M
shares outstanding. The number of shares has increased by 31.55%
in one year.
Shares Outstanding 19.25M Shares Change (YoY) 31.55% Shares Change (QoQ) 0% Owned by Institutions (%) 17.89% Shares Floating 19.07M Failed to Deliver (FTD) Shares 3,738 FTD / Avg. Volume 2.98%
Short Selling Information The latest short interest is 462.84K, so 2.64% of the outstanding
shares have been sold short.
Short Interest 462.84K Short % of Shares Out 2.64% Short % of Float 2.65% Short Ratio (days to cover) 5.66
Valuation Ratios The PE ratio is -2.37 and the forward
PE ratio is -4.6.
enVVeno Medical's PEG ratio is
0.07.
PE Ratio -2.37 Forward PE -4.6 PS Ratio 0 Forward PS 12.4 PB Ratio 1.23 P/FCF Ratio -3.07 PEG Ratio 0.07
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for enVVeno Medical.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 20.88,
with a Debt / Equity ratio of 0.03.
Current Ratio 20.88 Quick Ratio 20.88 Debt / Equity 0.03 Debt / EBITDA -0.05 Debt / FCF -0.06 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-589.7K Employee Count 37 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -9.6% in the
last 52 weeks. The beta is 1.01, so enVVeno Medical's
price volatility has been higher than the market average.
Beta 1.01 52-Week Price Change -9.6% 50-Day Moving Average 4.35 200-Day Moving Average 3.44 Relative Strength Index (RSI) 49.84 Average Volume (20 Days) 125,233
Income Statement
Revenue n/a Gross Profit n/a Operating Income -23.83M Net Income -21.82M EBITDA -21.29M EBIT n/a Earnings Per Share (EPS) -1.27
Full Income Statement Balance Sheet The company has 1.75M in cash and 1.06M in
debt, giving a net cash position of 690K.
Cash & Cash Equivalents 1.75M Total Debt 1.06M Net Cash 690K Retained Earnings -151.85M Total Assets 36.58M Working Capital 32.59M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -16.84M
and capital expenditures -37K, giving a free cash flow of -16.88M.
Operating Cash Flow -16.84M Capital Expenditures -37K Free Cash Flow -16.88M FCF Per Share -0.98
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields NVNO does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for NVNO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 30, 2020. It was a
backward
split with a ratio of 1:25.
Last Split Date Nov 30, 2020 Split Type backward Split Ratio 1:25
Scores Altman Z-Score 7.85 Piotroski F-Score 3
